BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/27/2025 4:19:59 AM | Browse: 2 | Download: 0
Publication Name World Journal of Diabetes
Manuscript ID 112475
Country China
Category Endocrinology & Metabolism
Manuscript Type Basic Study
Article Title Fibroblast growth factor 1 alleviates diabetic nephropathy by reducing renal lipid accumulation in diabetic kidney
Manuscript Source Unsolicited Manuscript
All Author List Ying-Jian Li, He-Yu Ge, Gui-Gui Zhang, Hao-Yu Chen, Yu-Jia Xi, Kai Wang, Yin-Li Huang, Chi Zhang, Xia Fan and Xiao-Qing Yan
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China No. 82470453
National Natural Science Foundation of China No. 82370832
Natural Science Foundation of Zhejiang Province No. LY22H020005
The Summit Advancement Disciplines of Zhejiang Province (Wenzhou Medical University-Pharmaceutics)
Corresponding Author Xiao-Qing Yan, Associate Professor, School of Pharmaceutical Sciences, Wenzhou Medical University, University-Town, Wenzhou 325035, Zhejiang Province, China. yanxiaoqing@wmu.edu.cn
Key Words Fibroblast growth factor 1; Diabetic nephropathy; Lipid accumulation; AMP-activated protein kinase; Human kidney-2; Carnitine palmitoyl transferase 1 alpha
Core Tip Fibroblast growth factor 1 (FGF1) can effectively ameliorate diabetic nephropathy as reflected by improved renal function and alleviation of kidney morphological abnormalities. FGF1 alleviates renal lipid accumulation, as evidenced by decreased triglyceride content and repressed adipose differentiation-related protein expression, via inhibiting fatty acid uptake and promoting lipid catabolism in diabetic kidney. Mechanical studies demonstrated that FGF1 modulates renal lipid metabolism via restoring AMP-activated protein kinase activity and peroxisome proliferator-activated receptor alpha expression.
Citation Li YJ, Ge HY, Zhang GG, Chen HY, Xi YJ, Wang K, Huang YL, Zhang C, Fan X, Yan XQ. Fibroblast growth factor 1 alleviates diabetic nephropathy by reducing renal lipid accumulation in diabetic kidney. World J Diabetes 2025; In press
Received
2025-07-28 14:35
Peer-Review Started
2025-08-04 06:33
To Make the First Decision
Return for Revision
2025-08-14 09:18
Revised
2025-10-12 13:02
Second Decision
2025-11-18 09:53
Accepted by Journal Editor-in-Chief
2025-11-24 10:13
Accepted by Executive Editor-in-Chief
2025-11-27 04:19
Articles in Press
2025-11-27 04:19
Publication Fee Transferred
2025-10-14 02:15
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com